| Symbol | SCLX |
|---|---|
| Name | SCILEX HOLDING CO |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 960 SAN ANTONIO ROAD, PALO ALTO, CA 94303 |
| Telephone | (650) 516-4310 |
| Fax | — |
| — | |
| Website | https://www.scilexholding.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001820190 |
| Description | Scilex Holding Company is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. ZTlido (lidocaine topical system) 1.8% is a prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of neuropathic pain associated with post-herpetic neuralgia. We have acquired two FDA approved non-opioid pain products, GLOPERBA and ELYXYB, for the treatment of gout in adults and oral solution for the acute treatment of migraine, with or without aura, in adults. Our product candidates include SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA TM), a Phase 3, novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, SP-103 (lidocaine topical system) 5. Additional info from NASDAQ: |
SCLX Stock Acquisition JV LLC 🔴 sold 500.0K shares of Scilex Holding Co (SCLX) Transaction Date: Jul 03, 2026 | Filing ID: 297858
Read moreNew Form SCHEDULE 13D/A - Scilex Holding Co <b>Filed:</b> 2026-07-07 <b>AccNo:</b> 0001193125-26-297859 <b>Size:</b> 256 KB
Read moreScilex Holding Company Announces Dream Bowl I Meme Coin Tokens Commence Trading on the Biconomy Exchange on July 6, 2026
Read moreScilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
Read moreScilex Holding Company Announces Dream Bowl I Meme Coin Tokens to List on Biconomy Exchange as Early as June 23, 2026
Read moreScilex Holding Company (“Scilex”) Confirms the Previously Announced Payment Date of June 15, 2026 for the Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities
Read moreNew Form EFFECT - Scilex Holding Co <b>Filed:</b> 2026-06-11 <b>AccNo:</b> 9999999995-26-001971 <b>Size:</b> 1 KB
Read more